Results 111 to 120 of about 137,221 (160)

The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study. [PDF]

open access: yesFront Pharmacol
Markovic U   +16 more
europepmc   +1 more source

Primary Splenic Classic Hodgkin Lymphoma with Immune Thrombocytopenic Purpura and Extramedullary Hematopoiesis. [PDF]

open access: yesInt J Surg Pathol
Elsharawi I   +5 more
europepmc   +1 more source

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up. [PDF]

open access: yesRes Pract Thromb Haemost
Schimmer R   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy